Participants 410 449 5
patients with severe acute pancreatitis
Participants 459 521 8
One hundred seventy-six patients with necrotizing pancreatitis
Participants 1115 1318 3
patients treated with meropenem and those treated with imipenem in terms of incidence of pancreatic infection (11.4% versus 13.6%) and extrapancreatic infections (21.6% versus 23.9%) and clinical outcome
Participants 1396 1435 3
patients with severe acute pancreatitis
